Bode, B. | bioRxiv Science

bioRxiv2023

CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23

CRISPR provides adaptive immunity in prokaryotes. Type III CRISPR systems detect invading RNA and activate the catalytic Cas10 subunit, which generates a range of nucleotide second messengers to signal infection. These molecules bind and activate a diverse range of effector proteins that provide immunity by degrading viral components and/or by disturbing key aspects of cellular metabolism to slow down viral replication. Here, we focus on the uncharacterised effector Csx23, which is widespread in Vibrio cholerae. Csx23 provides immunity against plasmids and phage when expressed in Escherichia coli along with its cognate type III CRISPR system. The Csx23 protein localises in the membrane using a N-terminal transmembrane -helical domain and has a cytoplasmic C-terminal domain that binds cyclic tetra-adenylate (cA4), activating its defence function. Structural studies reveal a tetrameric structure with a novel fold that binds cA4 specifically. Using pulse EPR, we demonstrate that cA4 binding to the cytoplasmic domain of Csx23 results in a major perturbation of the transmembrane domain, consistent with the opening of a pore and/or disruption of membrane integrity. This work reveals a new class of cyclic nucleotide binding protein and provides key mechanistic detail on a membrane-associated CRISPR effector.

microbiology↗

bioRxiv2018

Spatial structure increases the benefits of antibiotic production in Streptomyces griseus

Bacteria in the soil compete for limited resources to survive and proliferate. One of the ways they might do this is by producing antibiotics, but the costs of antibiotic production and their low concentrations in soils have led to uncertainty about the role of these natural products for the bacteria that produce them. Here, we examine the fitness effects of streptomycin production by the filamentous soil bacterium Streptomyces griseus and the conditions that modify its ability to invade competitors. Using pairwise competion assays, we first provide direct evidence that streptomycin production enables S. griseus to kill and invade a population of the susceptible species, S. coelicolor, but not a streptomycin-resistant mutant of this species. Next we show that the fitness benefits of streptomycin production are density-dependent, because production scales positively with cell number, and frequency-dependent, with a threshold of invasion of S. griseus at around 1%. Finally, using serial transfer experiments where spatial structure is either maintained or periodically destroyed, we show that spatial structure reduces the threshold frequency of invasion by more than 100-fold, indicating that antibiotic production can permit invasion from extreme rarity. Our results provide clear evidence that streptomycin is both an offensive and defensive weapon that facilitates invasion into occupied habitats and also protects against invasion by competitors. They also indicate that the benefits of antibiotic production rely on ecological interactions occurring at small local scales, suggesting that low antibiotic concentrations in bulk soil are unlikely to be representative of their effective concentrations in nature.

microbiology↗